Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Saskatchewan Flax Development Commission (SaskFlax) is a producer-led organization established in 1996 to represent and promote the interests of flax growers in Saskatchewan, Canada. While primarily an agricultural entity, SaskFlax is deeply involved in the life sciences sector through its extensive funding of research into the nutritional and therapeutic benefits of flaxseed. The commission supports clinical and laboratory studies focusing on the health impacts of alpha-linolenic acid (ALA), lignans, and dietary fiber on conditions such as cardiovascular disease and diabetes. By bridging the gap between agriculture and healthcare, SaskFlax facilitates the development of flax as a high-value functional food and nutraceutical ingredient. Their work includes collaborating with academic institutions to validate health claims and improve the nutritional profile of flax varieties.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saskatchewan Flax Development Commission.